Clinical manifestations are complex and often involve multiple systemic strain. Early identification and standardized clinical treatment are essential for improving prognosis. The diagnosis of this disease requires a combination of clinical manifestations, imaging checks, laboratory tests and pathological activation.
The platform can help align national and international experts and teams to provide accurate diagnosis and treatment programs. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many formerly difficult-to-treat neurological diseases have been significantly improved. Treatment needs to closely monitor efficacy and adverse reactions, adapting timely to changes in the course of treatment.
Multidisciplinary collaboration (MDT) is particularly important for the integrated management of tear thrombosis. 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.